Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma

Several immunomodulatory checkpoint inhibitors have been approved for the treatment of patients with advanced melanoma, including ipilimumab, nivolumab and pembrolizumab. Talimogene laherparepvec is the first oncolytic virus to gain regulatory approval in the USA; it is also approved in Europe. Tali...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Immunol Immunother
Huvudupphovsmän: Hoeller, Christoph, Michielin, Olivier, Ascierto, Paolo A., Szabo, Zsolt, Blank, Christian U.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Berlin Heidelberg 2016
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4995227/
https://ncbi.nlm.nih.gov/pubmed/27372293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-016-1860-3
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk